Literature DB >> 19484187

Circulating blood monocytes traffic to and participate in the periprosthetic tissue inflammation.

Kai Zhang1, Tang-Hong Jia, David McQueen, Wei-Ming Gong, David C Markel, Paul H Wooley, Shang-You Yang.   

Abstract

OBJECTIVE: To examine the trafficking of human circulating blood monocytes and their influence on the inflammation of periprosthetic tissues using a novel mouse-human chimera model.
METHODS: Periprosthetic tissue and bone chips from patients with aseptic prosthetic loosening were implanted into the muscles of immune-deficient SCID mice depleted of host macrophages by periodic intraperitoneal injection of anti-asialo GM1 rabbit sera (ASGM1). Autologous patient peripheral blood monocytes (PBMCs) were labeled with PKH2 fluorescent dye and injected intraperitoneally into the implanted animals. Mice were sacrificed 14 days after PBMC transfusion for molecular and histological analyses.
RESULTS: Patient periprosthetic tissues were well tolerated in SCID mice and preserved a high level of viability. Cell trafficking studies revealed the accumulation of fluorescent PBMC within the xenografts, with total cell counts in the xenografts significantly increased following the systemic PBMC infusion. PBMC infusion also promoted the expression of IL-1, IL-6, TNFalpha, and RANK within the periprosthetic tissue.
CONCLUSION: Systemic PBMC migrated to the implanted periprosthetic tissues and contributed to the local inflammation. The data provide evidence that circulating blood monocytes may play a role in pathologic process during aseptic loosening of total joint replacement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19484187      PMCID: PMC2863076          DOI: 10.1007/s00011-009-0051-5

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  30 in total

Review 1.  Wear and periprosthetic osteolysis: the problem.

Authors:  W H Harris
Journal:  Clin Orthop Relat Res       Date:  2001-12       Impact factor: 4.176

2.  Optical imaging of PKH-labeled hematopoietic cells in recipient bone marrow in vivo.

Authors:  Nadir Askenasy; Daniel L Farkas
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

3.  Composition and morphology of wear debris in failed uncemented total hip replacement.

Authors:  A S Shanbhag; J J Jacobs; T T Glant; J L Gilbert; J Black; J O Galante
Journal:  J Bone Joint Surg Br       Date:  1994-01

4.  Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.

Authors:  H Yoshino; T Ueda; M Kawahata; K Kobayashi; Y Ebihara; A Manabe; R Tanaka; M Ito; S Asano; T Nakahata; K Tsuji
Journal:  Bone Marrow Transplant       Date:  2000-12       Impact factor: 5.483

5.  Importance of hydroxyapatite particles characteristics on cytokines production by human monocytes in vitro.

Authors:  Patrice Laquerriere; Alexia Grandjean-Laquerriere; Edouard Jallot; Gerard Balossier; Patrick Frayssinet; Moncef Guenounou
Journal:  Biomaterials       Date:  2003-07       Impact factor: 12.479

6.  IL-1Ra and vIL-10 gene transfer using retroviral vectors ameliorates particle-associated inflammation in the murine air pouch model.

Authors:  S Yang; B Wu; L Mayton; C H Evans; P D Robbins; P H Wooley
Journal:  Inflamm Res       Date:  2002-07       Impact factor: 4.575

7.  Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis.

Authors:  S-Y Yang; B Wu; L Mayton; P Mukherjee; P D Robbins; C H Evans; P H Wooley
Journal:  Gene Ther       Date:  2004-03       Impact factor: 5.250

8.  Improved engraftment of human tumours in SCID mice pretreated with radiation and anti-asialo GM1.

Authors:  B Shpitz; B J Fernandes; J B Mullen; J C Roder; S Gallinger
Journal:  Anticancer Res       Date:  1994 Sep-Oct       Impact factor: 2.480

9.  High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1.

Authors:  B Shpitz; C A Chambers; A B Singhal; N Hozumi; B J Fernandes; C M Roifman; L M Weiner; J C Roder; S Gallinger
Journal:  J Immunol Methods       Date:  1994-02-28       Impact factor: 2.303

10.  A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice.

Authors:  T Geiler; J Kriegsmann; G M Keyszer; R E Gay; S Gay
Journal:  Arthritis Rheum       Date:  1994-11
View more
  7 in total

Review 1.  The basic science of periprosthetic osteolysis.

Authors:  M J Archibeck; J J Jacobs; K A Roebuck; T T Glant
Journal:  Instr Course Lect       Date:  2001

2.  Titanium particles: An emerging risk factor for peri-implant bone loss.

Authors:  Zoë Berryman; Laura Bridger; Haizal Mohd Hussaini; Alison M Rich; Momen Atieh; Andrew Tawse-Smith
Journal:  Saudi Dent J       Date:  2019-10-08

3.  The basic science of periprosthetic osteolysis.

Authors:  Stuart B Goodman; Emmanuel Gibon; Zhenyu Yao
Journal:  Instr Course Lect       Date:  2013

Review 4.  Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement.

Authors:  S B Goodman; E Gibon; J Pajarinen; T-H Lin; M Keeney; P-G Ren; C Nich; Z Yao; K Egashira; F Yang; Y T Konttinen
Journal:  J R Soc Interface       Date:  2014-01-29       Impact factor: 4.118

5.  Titanium particle-challenged osteoblasts promote osteoclastogenesis and osteolysis in a murine model of periprosthestic osteolysis.

Authors:  Yunpeng Jiang; Tanghong Jia; Weiming Gong; Paul H Wooley; Shang-You Yang
Journal:  Acta Biomater       Date:  2013-03-19       Impact factor: 8.947

6.  Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening.

Authors:  H Wang; T-H Jia; N Zacharias; W Gong; H-X Du; P H Wooley; S-Y Yang
Journal:  Gene Ther       Date:  2012-02-09       Impact factor: 5.250

7.  Biological Impact of Silicon Nitride for Orthopaedic Applications: Role of Particle Size, Surface Composition and Donor Variation.

Authors:  Saurabh Lal; Emily A Caseley; Richard M Hall; Joanne L Tipper
Journal:  Sci Rep       Date:  2018-06-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.